287 related articles for article (PubMed ID: 21790966)
1. Biomarkers in advanced heart failure: diagnostic and therapeutic insights.
Nagarajan V; Tang WH
Congest Heart Fail; 2011; 17(4):169-74. PubMed ID: 21790966
[TBL] [Abstract][Full Text] [Related]
2. [Clinical usefulness of biomarkers in cardiac failure].
Paredes C A; Vega J; de León A; Kanacri A; Castro P; Baeza R
Rev Med Chil; 2013 Dec; 141(12):1560-9. PubMed ID: 24728434
[TBL] [Abstract][Full Text] [Related]
3. [Role of biomarkers for risk stratification in the tailored follow-up of heart failure patients].
Aspromonte N; Di Tano G; Latini R; Masson S; Valle R; Emdin M
G Ital Cardiol (Rome); 2010 May; 11(5 Suppl 2):17S-23S. PubMed ID: 20873464
[TBL] [Abstract][Full Text] [Related]
4. Combining natriuretic peptides and necrosis markers in determining prognosis in heart failure.
Fonarow GC; Horwich TB
Rev Cardiovasc Med; 2003; 4 Suppl 4():S20-8. PubMed ID: 14564225
[TBL] [Abstract][Full Text] [Related]
5. Complementary prognostic value of cystatin C, N-terminal pro-B-type natriuretic Peptide and cardiac troponin T in patients with acute heart failure.
Manzano-Fernández S; Boronat-Garcia M; Albaladejo-Otón MD; Pastor P; Garrido IP; Pastor-Pérez FJ; Martínez-Hernández P; Valdés M; Pascual-Figal DA
Am J Cardiol; 2009 Jun; 103(12):1753-9. PubMed ID: 19539088
[TBL] [Abstract][Full Text] [Related]
6. Risk stratification in acute decompensated heart failure: the role of cardiac troponin.
Mueller C
Nat Clin Pract Cardiovasc Med; 2008 Nov; 5(11):680-1. PubMed ID: 18779830
[TBL] [Abstract][Full Text] [Related]
7. Biomarkers.
Florea VG; Anand IS
Heart Fail Clin; 2012 Apr; 8(2):207-24. PubMed ID: 22405661
[TBL] [Abstract][Full Text] [Related]
8. Biomarkers after heart transplantation: nongenomic.
Dengler TJ; Gleissner CA; Klingenberg R; Sack FU; Schnabel PA; Katus HA
Heart Fail Clin; 2007 Jan; 3(1):69-81. PubMed ID: 17545010
[TBL] [Abstract][Full Text] [Related]
9. Old and new biomarkers of heart failure.
Emdin M; Vittorini S; Passino C; Clerico A
Eur J Heart Fail; 2009 Apr; 11(4):331-5. PubMed ID: 19329823
[TBL] [Abstract][Full Text] [Related]
10. Natriuretic peptide testing for heart failure therapy guidance in the inpatient and outpatient setting.
Green SM; Green JA; Januzzi JL
Am J Ther; 2009; 16(2):171-7. PubMed ID: 19300043
[TBL] [Abstract][Full Text] [Related]
11. Natriuretic peptides and other biomarkers in chronic heart failure: from BNP, NT-proBNP, and MR-proANP to routine biochemical markers.
Lainscak M; von Haehling S; Anker SD
Int J Cardiol; 2009 Mar; 132(3):303-11. PubMed ID: 19144431
[TBL] [Abstract][Full Text] [Related]
12. Importance of myocardial damage in acute decompensated heart failure: changing the paradigm from a passive to an active process.
Perna ER; Címbaro Canella JP; Macin SM
Minerva Cardioangiol; 2005 Dec; 53(6):523-35. PubMed ID: 16333236
[TBL] [Abstract][Full Text] [Related]
13. Cardiac troponin levels in heart failure.
Potluri S; Ventura HO; Mulumudi M; Mehra MR
Cardiol Rev; 2004; 12(1):21-5. PubMed ID: 14667259
[TBL] [Abstract][Full Text] [Related]
14. [Cardiac biomarkers in perioperative risk stratification].
Fellahi JL; Piriou V; Longrois D
Ann Fr Anesth Reanim; 2011 Feb; 30(2):126-40. PubMed ID: 21282034
[TBL] [Abstract][Full Text] [Related]
15. Are multiple biomarker testing strategies ready for prime time in heart failure?
Lee DS; Tu JV
Circ Heart Fail; 2009 Sep; 2(5):387-8. PubMed ID: 19808366
[No Abstract] [Full Text] [Related]
16. Combination of conventional biomarkers for risk stratification in chronic heart failure.
Niizeki T; Takeishi Y; Kitahara T; Suzuki S; Sasaki T; Ishino M; Kubota I
J Cardiol; 2009 Apr; 53(2):179-87. PubMed ID: 19304120
[TBL] [Abstract][Full Text] [Related]
17. [Redefinition of myocardial infarction--relevance of biomarkers].
Weber M; Hamm C
Herz; 2008 Mar; 33(2):115-21. PubMed ID: 18344030
[TBL] [Abstract][Full Text] [Related]
18. Pro-B-type natriuretic peptide levels in acute decompensated heart failure.
Waldo SW; Beede J; Isakson S; Villard-Saussine S; Fareh J; Clopton P; Fitzgerald RL; Maisel AS
J Am Coll Cardiol; 2008 May; 51(19):1874-82. PubMed ID: 18466803
[TBL] [Abstract][Full Text] [Related]
19. Pathophysiology, prognostic significance and clinical utility of B-type natriuretic peptide in acute coronary syndromes.
Wiviott SD; de Lemos JA; Morrow DA
Clin Chim Acta; 2004 Aug; 346(2):119-28. PubMed ID: 15256312
[TBL] [Abstract][Full Text] [Related]
20. Novel biomarkers for heart failure.
Iqbal N; Alim KS; Aramin H; Iqbal F; Green E; Higginbotham E; Maisel AS
Expert Rev Cardiovasc Ther; 2013 Sep; 11(9):1155-69. PubMed ID: 23980627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
